Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 18, 2018
Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial
Pedro Cahn, Paul E Sax, Kathleen Squires, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 28, 2025
Anal Cancer Screening in People Living with HIV: A Pilot Study of Primary HPV Screening with Triage Use of p16/Ki67 Dual Stain
Ian K J Wong, Clare E F Dyer, Andrew E Grulich, et al.
AIDS (London, England)
|
June 27, 2020
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV
Samira Hosseini-Hooshyar, Marianne Martinello, Jasmine Yee, et al.
Sexually Transmitted Infections
|
June 20, 2024
Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance data
Brendan L Harney, Rachel Sacks-Davis, Michael Traeger, et al.
AIDS Research and Human Retroviruses
|
March 14, 2017
Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy
William J Hey-Nguyen, Yin Xu, Chester F Pearson, et al.
AIDS (London, England)
|
December 20, 2015
Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study
Jan van Lunzen, Andrea Antinori, Calvin J Cohen, et al.
AIDS Patient Care and Stds
|
January 10, 2023
Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial
Tahilin Sanchez Karver, Miguel Pascual-Bernaldez, Alessandro Berni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 5, 2019
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study
Marianne Martinello, Jasmine Yee, Sofia R Bartlett, et al.
Plos Medicine
|
November 5, 2004
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1
Frank van Leth, Prahpan Phanuphak, Erik Stroes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2021
The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019
Brendan L Harney, Rachel Sacks-Davis, Daniela K van Santen, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 18, 2018
Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial
Pedro Cahn, Paul E Sax, Kathleen Squires, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 28, 2025
Anal Cancer Screening in People Living with HIV: A Pilot Study of Primary HPV Screening with Triage Use of p16/Ki67 Dual Stain
Ian K J Wong, Clare E F Dyer, Andrew E Grulich, et al.
AIDS (London, England)
|
June 27, 2020
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV
Samira Hosseini-Hooshyar, Marianne Martinello, Jasmine Yee, et al.
Sexually Transmitted Infections
|
June 20, 2024
Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance data
Brendan L Harney, Rachel Sacks-Davis, Michael Traeger, et al.
AIDS Research and Human Retroviruses
|
March 14, 2017
Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy
William J Hey-Nguyen, Yin Xu, Chester F Pearson, et al.
AIDS (London, England)
|
December 20, 2015
Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study
Jan van Lunzen, Andrea Antinori, Calvin J Cohen, et al.
AIDS Patient Care and Stds
|
January 10, 2023
Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial
Tahilin Sanchez Karver, Miguel Pascual-Bernaldez, Alessandro Berni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 5, 2019
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study
Marianne Martinello, Jasmine Yee, Sofia R Bartlett, et al.
Plos Medicine
|
November 5, 2004
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1
Frank van Leth, Prahpan Phanuphak, Erik Stroes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2021
The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019
Brendan L Harney, Rachel Sacks-Davis, Daniela K van Santen, et al.
Page
of 9